Evidence map›Paper›PMID 41311975›Full record

ArticleFrontiers in bioengineering and biotechnology2025

Magnetic drug-loaded microbubbles for treating lower limb venous thrombosis under controllable rotating magnetic field.

Yu-Ming Huang, Cheng-Rang Liu, Yi-Qi Xu, Chao Cao, Zhen-Gan Huang, Yu Zhang, Hong-Wen Fei, Yue-Shan Huang

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Yu-Ming Huang *School of Medicine, South China University of Technology, Guangzhou, China.
Cheng-Rang Liu *School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong, China.
Yi-Qi Xu *Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chao Cao *School of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong, China.
Zhen-Gan HuangGuangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yu ZhangSchool of Medicine, South China University of Technology, Guangzhou, China.
Hong-Wen FeiGuangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yue-Shan HuangSchool of Materials Science and Engineering, South China University of Technology, Guangzhou, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to develop a poly (lactic-co-glycolic acid) (PLGA)-based magnetic loaded iron oxide (Fe Background: Acute thrombotic disorders are significant health threats, however, the exploration of magnetic actuation as a treatment for acute thrombosis has been limited. Methods: Magnetic microbubbles were prepared using a double emulsion method, loaded with Fe Results: Fe Conclusion: This novel magnetic drug delivery system, combined with a rotating magnetic field, demonstrates excellent thrombolysis efficiency and presents a promising and safe therapeutic strategy for acute venous thrombosis.

Indexed as

acute lower limb venous thrombosismagnetic drug deliverypoly (lactic-co-glycolic acid) microbubblesrotating magnetic fieldsingle-chain urokinase-type plasminogen activator (proUK)thrombolysis

Identifiers

PMID41311975
PMCPMC12650771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.